Results 211 to 220 of about 114,838 (244)

A Hierarchical Risk Assessment Framework for Population-Specific Statin Safety Labelling. [PDF]

Pharmacoepidemiol Drug Saf
Tsui L.
europepmc   +1 more source

Centering transgender voices as a path to equitable healthcare. [PDF]

Lancet Reg Health Am
Gualano B, Caruso Mazzolani B, Longobardi I, Roschel H, Saadeh A.   +4 more
europepmc   +1 more source

COBT: a gene-based rare variant burden test for case-only study designs using aggregated genotypes from public reference cohorts. [PDF]

Genome Med
Favier A, Chounta S, Garcia A, Jabot-Hanin F, Chen X, Garcelon N, Burgun A, Higueras M, Guilloux A, Benmerah A, Martin Y, Billot K, Rozet JM, Perrault I, Cormier-Daire V, Huber C, Zaidan M, Attie-Bitach T, Saunier S, Rausell A.   +19 more
europepmc   +1 more source

Inference in group sequential designs with causal mechanisms: implications for power and mediation analysis. [PDF]

BMC Med Res Methodol
Lee KM, Emsley R.
europepmc   +1 more source

LOXL2 labels inflammation-associated myofibroblasts predicting kidney allograft dysfunction and fibrosis. [PDF]

Front Immunol
Schütz P, Hüchtmann B, Van Marck V, Heitplatz B, Walter C, Rixen R, Pavenstädt H, Reuter S, Buscher K.   +8 more
europepmc   +1 more source

Context-Stratified Mendelian Randomization: Exploiting Regional Exposure Variation to Explore Causal Effect Heterogeneity and Nonlinearity. [PDF]

Stat Med
Burgess S, Woolf BAR, Mason AM.
europepmc   +1 more source

Selling and rejecting politics with history : Historiography in defence of dualism and monarchy in late medieval and reformation Sweden

, 2007
Tjällén, Biörn,
core